Careers  |  Sign In  |  Register  |   Twitter

Latest in Oncology

The Huffington Post reports that a new study published in the Journal of Clinical Oncology has found that body mass index (BMI) may be linked to survival rates of pancreatic cancer patients. The study analyzed prediagnostic BMIs of 902 patients diagnosed with pancreatic cancer between 1988 and 2010....
Reuters reports that most doctors do not discuss the risks of cancer screening. Risks of cancer screening include what is known as “over-diagnosis,” which can be diagnosing a tumor that is not present or diagnosing a tumor that is so small and slow-growing that it wouldn’t cause a problem....
Reuters reports that Adriad Pharmaceuticals Inc. has discontinued a late-stage trial of its leukemia drug, Iclusig. The drug, which was approved by the FDA for two forms of blood cancer, has now been shown to cause blood clots. Though the drug’s shares have now plunged to a three-year low of $2.62, it...